Table of Contents

Highlights

• Highlights of This Issue

  Clin Cancer Res March 1, 2013 19:5 953
  • Full Text
  • Full Text (PDF)

CCR Translations

• Select this article

  Reading the Tea Leaves of Tumor-Mediated Immunosuppression

  • Rimas J. Orentas

  Clin Cancer Res March 1, 2013 19:5 955-957; Published OnlineFirst February 21, 2013; doi:10.1158/1078-0432.CCR-12-3792
  • Abstract
  • Full Text
  • Full Text (PDF)
  • Figures Only
• Select this article

  Can the “Right” EGFR-Specific mAb Dramatically Improve EGFR-Targeted Therapy?

  • Francesco Sabbatino and
  • Soldano Ferrone

  Clin Cancer Res March 1, 2013 19:5 958-960; Published OnlineFirst January 22, 2013; doi:10.1158/1078-0432.CCR-12-3586
  • Abstract
  • Full Text
  • Full Text (PDF)
  • Figures Only

CCR New Strategies

• Select this article

  New Strategies in the Treatment of Ovarian Cancer: Current Clinical Perspectives and Future Potential

  • Susana Banerjee and
  • Stanley B. Kaye

  Clin Cancer Res March 1, 2013 19:5 961-968; Published OnlineFirst January 10, 2013; doi:10.1158/1078-0432.CCR-12-2243
  • Abstract
  • Full Text
  • Full Text (PDF)
  • Figures Only

Statistics in Clinical Cancer Research

• Select this article

  Evaluation of Progression-Free Survival as a Surrogate Endpoint for Survival in Chemotherapy and Targeted Agent Metastatic Colorectal Cancer Trials

  • Roger Sidhu,
  • Alan Rong,
  • and Steve Dahlberg

  Clin Cancer Res March 1, 2013 19:5 969-976; Published OnlineFirst January 9, 2013; doi:10.1158/1078-0432.CCR-12-2502
  • Abstract
  • Full Text
  • Full Text (PDF)
  • Figures Only
  • Supplementary Data

Molecular Pathways

• Select this article

  Molecular Pathways: Targeting PARP in Cancer Treatment

  • Khanh Do and
  • Alice P. Chen

  Clin Cancer Res March 1, 2013 19:5 977-984; Published OnlineFirst December 26, 2012; doi:10.1158/1078-0432.CCR-12-0163
  • Abstract
  • Full Text
  • Full Text (PDF)
  • Figures Only

Review

• Select this article

  Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple Myeloma: A Review of the Current Understanding of Epidemiology, Biology, Risk Stratification, and Management of Myeloma Precursor Disease

  • Amit Agarwal and
  • Irene M. Ghobrial

  Clin Cancer Res March 1, 2013 19:5 985-994; Published OnlineFirst December 5, 2012; doi:10.1158/1078-0432.CCR-12-2922
  • Abstract
  • Full Text
  • Full Text (PDF)
  • Figures Only
  • Supplementary Data

CCR Focus

• Waking the Immune System at Last

  • Susan E. Bates

  Clin Cancer Res March 1, 2013 19:5 996; doi:10.1158/1078-0432.CCR-13-0274
  • Full Text
  • Full Text (PDF)
• Select this article

  Clinical Development of Immunostimulatory Monoclonal Antibodies and Opportunities for Combination

  • Ignacio Melero,
  • Antonio M. Grimaldi,
  • Jose L. Perez-Gracia,
  • and Paolo A. Ascierto

  Clin Cancer Res March 1, 2013 19:5 997-1008; doi:10.1158/1078-0432.CCR-12-2214
  • Abstract
  • Full Text
  • Full Text (PDF)
  • Figures Only
• Select this article

  Biomarkers for Immunostimulatory Monoclonal Antibodies in Combination Strategies for Melanoma and Other Tumor Types

  • Paolo A. Ascierto,
  • Michael Kalos,
  • David A. Schaer,
  • Margaret K. Callahan,
  • and Jedd D. Wolchok

  Clin Cancer Res March 1, 2013 19:5 1009-1020; doi:10.1158/1078-0432.CCR-12-2982
  • Abstract
  • Full Text
  • Full Text (PDF)
  • Figures Only
• Select this article

  Antagonist Antibodies to PD-1 and B7-H1 (PD-L1) in the Treatment of Advanced Human Cancer

  • Mario Sznol and
  • Lieping Chen

  Clin Cancer Res March 1, 2013 19:5 1021-1034; doi:10.1158/1078-0432.CCR-12-2063
  • Abstract
  • Full Text
  • Full Text (PDF)
  • Figures Only
• Select this article

  Agonistic CD40 Antibodies and Cancer Therapy

  • Robert H. Vonderheide and
  • Martin J. Glennie

  Clin Cancer Res March 1, 2013 19:5 1035-1043; doi:10.1158/1078-0432.CCR-12-2064
  • Abstract
  • Full Text
  • Full Text (PDF)
  • Figures Only
• Select this article

  Agonist Antibodies to TNFR Molecules That Costimulate T and NK Cells

  • Ignacio Melero,
  • Daniel Hirschhorn-Cymerman,
  • Aizea Morales-Kastresana,
  • Miguel F. Sanmamed,
  • and Jedd D. Wolchok

  Clin Cancer Res March 1, 2013 19:5 1044-1053; doi:10.1158/1078-0432.CCR-12-2065
  • Abstract
  • Full Text
  • Full Text (PDF)
  • Figures Only
• Select this article

  Use of Oligonucleotide Aptamer Ligands to Modulate the Function of Immune Receptors

  • Eli Gilboa,
  • James McNamara II,
  • and Fernando Pastor

  Clin Cancer Res March 1, 2013 19:5 1054-1062; doi:10.1158/1078-0432.CCR-12-2067
  • Abstract
  • Full Text
  • Full Text (PDF)
  • Figures Only

Human Cancer Biology

• Select this article

  Modeling Boundary Conditions for Balanced Proliferation in Metastatic Latency

  • Donald P. Taylor,
  • Jakob Z. Wells,
  • Andrej Savol,
  • Chakra Chennubhotla,
  • and Alan Wells

  Clin Cancer Res March 1, 2013 19:5 1063-1070; Published OnlineFirst January 17, 2013; doi:10.1158/1078-0432.CCR-12-3180
  • Abstract
  • Full Text
  • Full Text (PDF)
  • Figures Only
• Select this article

  ZEB1 Promotes Invasiveness of Colorectal Carcinoma Cells through the O